Susan Neo - FOXO Technologies Chief Officer
| FOXO Stock | USD 0.52 0.01 1.96% |
Insider
Susan Neo is Chief Officer of FOXO Technologies
| Address | 729 North Washington Avenue, Minneapolis, MN, United States, 55401 |
| Phone | 612 562 9447 |
| Web | https://foxotechnologies.com |
FOXO Technologies Management Efficiency
The company has return on total asset (ROA) of (1.1366) % which means that it has lost $1.1366 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.545) %, meaning that it created substantial loss on money invested by shareholders. FOXO Technologies' management efficiency ratios could be used to measure how well FOXO Technologies manages its routine affairs as well as how well it operates its assets and liabilities. At this time, FOXO Technologies' Return On Capital Employed is very stable compared to the past year. As of the 29th of November 2024, Return On Equity is likely to grow to 1.97, though Return On Tangible Assets are likely to grow to (72.42). At this time, FOXO Technologies' Other Assets are very stable compared to the past year. As of the 29th of November 2024, Intangibles To Total Assets is likely to grow to 0.55, while Total Assets are likely to drop about 688.8 K.Similar Executives
| Showing other executives | INSIDER Age | ||
| Denise Pufal | Nutex Health | N/A | |
| Ken Persen | Heartbeam | N/A | |
| Steven Sobak | EUDA Health Holdings | 78 | |
| Shibu Kizhakevilayil | Healthcare Triangle | 52 | |
| Branislav Vajdic | Heartbeam | 69 | |
| Elizabeth Hall | Nutex Health | N/A | |
| Thyagarajan Ramachandran | Healthcare Triangle | 48 | |
| Vivian MBA | Nutex Health | N/A | |
| Michael Gill | Healthcare Triangle | 46 | |
| Daniel Tan | EUDA Health Holdings | 43 | |
| Lawrence FACS | Nutex Health | 75 | |
| Jon Hunt | Heartbeam | 68 | |
| Richard Brounstein | Heartbeam | 74 | |
| LaChoenda Rosales | Nutex Health | N/A | |
| Kristi Lane | Healthcare Triangle | N/A | |
| Wei Chen | EUDA Health Holdings | 39 | |
| John Lorbiecki | Aclarion | 61 | |
| Sudish Mogli | Healthcare Triangle | 55 | |
| Lakshmanan Kannappan | Healthcare Triangle | 57 | |
| MD MBA | Nutex Health | 51 | |
| Jon Bates | Nutex Health | 54 | |
Management Performance
| Return On Equity | -17.55 | ||||
| Return On Asset | -1.14 |
FOXO Technologies Leadership Team
Elected by the shareholders, the FOXO Technologies' board of directors comprises two types of representatives: FOXO Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FOXO. The board's role is to monitor FOXO Technologies' management team and ensure that shareholders' interests are well served. FOXO Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FOXO Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian Chen, Chief Officer | ||
| Steven Sabes, Chief Officer | ||
| Tyler Danielson, CTO CEO | ||
| Robert Potashnick, Chief Officer | ||
| Martin FCA, Interim Officer | ||
| Jim Grauel, Chief Officer | ||
| Susan Neo, Chief Officer | ||
| Mark White, Interim Director |
FOXO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is FOXO Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -17.55 | ||||
| Return On Asset | -1.14 | ||||
| Operating Margin | (56.75) % | ||||
| Current Valuation | 44.58 M | ||||
| Shares Outstanding | 17.48 M | ||||
| Shares Owned By Insiders | 11.99 % | ||||
| Shares Owned By Institutions | 2.25 % | ||||
| Number Of Shares Shorted | 53.71 K | ||||
| Price To Book | 0.91 X | ||||
| Price To Sales | 57.70 X |
Pair Trading with FOXO Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if FOXO Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FOXO Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with FOXO Stock
Moving against FOXO Stock
| 0.75 | EKSO | Ekso Bionics Holdings | PairCorr |
| 0.57 | VERO | Venus Concept | PairCorr |
| 0.42 | DRIO | DarioHealth Corp | PairCorr |
| 0.33 | CI | Cigna Corp | PairCorr |
The ability to find closely correlated positions to FOXO Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace FOXO Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back FOXO Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling FOXO Technologies to buy it.
The correlation of FOXO Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FOXO Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FOXO Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for FOXO Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FOXO Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. To learn how to invest in FOXO Stock, please use our How to Invest in FOXO Technologies guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FOXO Technologies. If investors know FOXO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FOXO Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.05 | Revenue Per Share 0.02 | Quarterly Revenue Growth 1.333 | Return On Assets (1.14) | Return On Equity (17.55) |
The market value of FOXO Technologies is measured differently than its book value, which is the value of FOXO that is recorded on the company's balance sheet. Investors also form their own opinion of FOXO Technologies' value that differs from its market value or its book value, called intrinsic value, which is FOXO Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FOXO Technologies' market value can be influenced by many factors that don't directly affect FOXO Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FOXO Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if FOXO Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FOXO Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.